Therapeutic Areas

Respiratory Cancers

Non-small cell lung cancer (NSCLC) and related malignancies. Our lead programs target high-unmet-need respiratory oncologies with computationally optimized mechanisms.

Gastrointestinal Cancers

Gastric, colorectal, and other GI malignancies. Leveraging proprietary target identification to address treatment-resistant GI tumors.

Melanoma & Breast Cancer

Clinically validated targets with clear development pathways. Programs advancing from dry-lab validation to in vitro confirmation.